Reappraisal of the glycerol test in patients with suspected Menière’s disease
Tóm tắt
Recent advances in magnetic resonance imaging make it possible to visualize the presumed pathophysiologic correlate of Menière’s disease: endolymphatic hydrops. As traditional diagnostic tests can provide only indirect evidence, they are hardly competitive in this respect and need to be rethought. This is done here for the glycerol test. The data of a previous retrospective analysis of the glycerol test in patients with suspected Menière’s disease are reinterpreted using a simple model. The mean threshold reduction (MTR) in the frequency range from 125 to 1500 Hz (calculated from audiograms obtained immediately before and four hours after the glycerol intake) is used as the test statistic. The proposed model explains the frequency distribution of the observed MTR by the convolution of a Gaussian probability density function (representing measurement errors) with a template representing the frequency distribution of the true MTR. The latter is defined in terms of two adjustable parameters. After fitting the model to the data, the performance of the test is evaluated using receiver operating characteristic (ROC) analysis. The cumulative frequency distribution of the observed MTR can be explained almost perfectly by the model. According to the ROC analysis performed, the capability of the currently used audiometric procedure to detect a glycerol-induced threshold reduction corresponds to a diagnostic test of rather high accuracy (area under the ROC curve greater than 0.9). Simulations show that methodological improvements could further enhance the performance. Owing to their ability to reveal functional aspects without an obvious morphological correlate, traditional test for Menière’s disease could be decisive for defining the stage of the disease. A distinctive feature of the glycerol test is that it is capable of determining, with high accuracy, whether the pathophysiologic condition of the inner ear is partially reversible. Prospectively, this could help to estimate the chances of specific therapies.
Tài liệu tham khảo
Atkinson M: Menière’s original papers; reprinted with an English translation together with commentaries and biographical sketch. Acta Otolaryngo (Stockh). 1961, Suppl. 162: 1-78.
Committee on Hearing and Equilibrium: Guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngol Head Neck Surg. 1995, 113 (3): 181-185.
Arts HA, Kileny PR, Telian SA: Diagnostic testing for endolymphatic hydrops. Otolaryngol Clin North Am. 1997, 30 (6): 987-1005.
Adams ME, Heidenreich KD, Kileny PR: Audiovestibular testing in patients with Meniere’s disease. Otolaryngol Clin North Am. 2010, 43 (5): 995-1009. 10.1016/j.otc.2010.05.008.
Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Nakata S, Katayama N, Ishida IM: Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope. 2007, 117 (3): 415-420. 10.1097/MLG.0b013e31802c300c.
Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T: Imaging of endolymphatic and perilymphatic fluid after intravenous administration of single-dose gadodiamide. Magn Reson Med Sci. 2012, 11 (2): 145-150. 10.2463/mrms.11.145.
Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T: Imaging of Ménière’s disease after intravenous administration of single-dose gadodiamide: Utility of multiplication of MR cisternography and HYDROPS image. Magn Reson Med Sci. 2013, 12 (1): 63-68. 10.2463/mrms.2012-0027.
Colletti V, Mandala M, Carner M, Barillari M, Cerini R, Pozzi Mucelli R, Colletti L: Evidence of gadolinium distribution from the endolymphatic sac to the endolymphatic compartments of the human inner ear. Audiol Neurootol. 2010, 15 (6): 353-363. 10.1159/000292929.
Yamamoto M, Teranishi M, Naganawa S, Otake H, Sugiura M, Iwata T, Yoshida T, Katayama N, Nakata S, Sone M, Nakashima T: Relationship between the degree of endolymphatic hydrops and electrocochleography. Audiology and Neuro-Otology. 2010, 15 (4): 254-260. 10.1159/000258681.
Gürkov R, Flatz W, Louza J, Strupp M, Ertl-Wagner B, Krause E: In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Ménière’s disease. Otol Neurotol. 2012, 33 (6): 1040-1045.
Pyykkö I, Nakashima T, Yoshida T, Zou J, Naganawa S: Ménière’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open. 2013, 3: e001555-
Fiorino F, Pizzini FB, Beltramello A, Mattellini B, Barbieri F: Reliability of magnetic resonance imaging performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Ménière’s disease. Otol Neurotol. 2011, 32 (3): 472-477. 10.1097/MAO.0b013e31820e7614.
Power M, Fell G, Wright M: Principles for high-quality, high-value testing. Evid Based Med. 2013, 18 (1): 5-10. 10.1136/eb-2012-100645.
Merchant SN, Adams JC, Nadol JB: Pathophysiology of Ménière’s syndrome: Are symptoms caused by endolymphatic hydrops?. Otol Neurotol. 2005, 26 (1): 74-81. 10.1097/00129492-200501000-00013.
Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K, Zingler VC, Mansmann U, Brandt T: Long-term prophylactic treatment of attacks of vertigo in Menière’s disease - comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 2008, 128 (5): 520-524. 10.1080/00016480701724912.
Klockhoff I, Lindblom U: Endolymphatic hydrops revealed by glycerol test. Preliminary report. Acta Otolaryngol. 1966, 61 (5): 459-462.
Minor LB, Schessel DA, Carey JP: Ménière’s disease. Curr Opin Neurol. 2004, 17 (1): 9-16. 10.1097/00019052-200402000-00004.
Belinchon A, Perez-Garrigues H, Tenias JM: Evolution of symptoms in Ménière’s disease. Audiol Neurootol. 2012, 17 (2): 126-132. 10.1159/000331945.
Klockhoff I: Glycerol test — some remarks after 15 years experience. Menière’s Disease: Pathogenesis, Diagnosis and Treatment. Edited by: Vosteen KH, Schuknecht H, Pfaltz CR, Wersäll J, Kimura RS, Morgenstern C, Juhn SK. 1981, New York: Thieme-Stratton Inc, 148-151.
Basel T, Lütkenhöner B: Auditory threshold shifts after glycerol administration to patients with suspected Menière’s disease: A retrospective analysis. Ear Hear. 2013, 34 (3): 370-384. 10.1097/AUD.0b013e31826d0c08.
Lütkenhöner B, Basel T: Predictive modeling for diagnostic tests with high specificity, but low sensitivity: a study of the glycerol test in patients with suspected Meniere’s disease. PLoS One. 2013, 8 (11): e79315-10.1371/journal.pone.0079315.
Basel T, Lütkenhöner B: Data from: Auditory threshold shifts after glycerol administration to patients with suspected Menière’s disease: a retrospective analysis. 2013,http://datadryad.org/resource/doi:10.5061/dryad.dr78n,
Stefanski L, Carroll RJ: Deconvoluting kernel density estimators. Statistics. 1990, 21 (2): 169-184. 10.1080/02331889008802238.
Lütkenhöner B: A family of kernels and their associated deconvolving kernels for normally distributed measurement errors. J Stat Comput Simul. 2014, doi:10.1080/00949655.2014.928712
Witting EG, Hughson W: Inherent accuracy of a series of repeated clinical audiograms. Laryngoscope. 1940, 50 (3): 259-269.
Gardner MB: A pulse-tone technique for clinical audiometric threshold measurements. J Acoust Soc Am. 1947, 19 (4): 592-599. 10.1121/1.1916526.
Atherley GR, Dingwall-Fordyce I: The Reliability of Repeated Auditory Threshold Determination. Br J Ind Med. 1963, 20: 231-235.
Hickling S: The Validity and Reliability of Pure Tone Clinical Audiometry. N Z Med J. 1964, 63: 379-382.
Chermak GD, Dengerink JE, Dengerink HA: Test-retest reliability of auditory threshold and temporary threshold shift. Scand Audiol. 1983, 12 (4): 237-240. 10.3109/01050398309044425.
Brown CD, Davis HT: Receiver operating characteristics curves and related decision measures: A tutorial. Chemometrics Intellig Lab Syst. 2006, 80 (1): 24-38. 10.1016/j.chemolab.2005.05.004.
Zou KH, O’Malley AJ, Mauri L: Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007, 115 (5): 654-657. 10.1161/CIRCULATIONAHA.105.594929.
Søreide K, Kørner H, Søreide JA: Diagnostic accuracy and receiver-operating characteristics curve analysis in surgical research and decision making. Ann Surg. 2011, 253 (1): 27-34. 10.1097/SLA.0b013e318204a892.
Swets J: Measuring the accuracy of diagnostic systems. Science. 1988, 240 (4857): 1285-1293. 10.1126/science.3287615.
Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y: Analysing and presenting results. Cochrane handbook for systematic reviews of diagnostic test accuracy. Edited by: Deeks JJ, Bossuyt PM, Gatsonis C. 2010, The Cochrane Collaboration, Available from: http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter%2010%20-%20Version%201.0.pdf
Studebaker GA: Intertest variability and the air-bone gap. J Speech Hear Disord. 1967, 32 (1): 82-86. 10.1044/jshd.3201.82.
Jerlvall L, Arlinger S: A comparison of 2-dB and 5-dB step size in pure-tone audiometry. Scand Audiol. 1986, 15 (1): 51-56. 10.3109/01050398609045954.
Stuart A, Stenstrom R, Tompkins C, Vandenhoff S: Test-retest variability in audiometric threshold with supraaural and insert earphones among children and adults. Audiology. 1991, 30 (2): 82-90. 10.3109/00206099109072873.
Wildner M: In memory of William of Occam. Lancet. 1999, 354 (9196): 2172-
Lecluyse W, Meddis R: A simple single-interval adaptive procedure for estimating thresholds in normal and impaired listeners. J Acoust Soc Am. 2009, 126 (5): 2570-2579. 10.1121/1.3238248.
Klockhoff I, Lindblom U: Glycerol test in Ménière’s disease. Acta Otolaryngol. 1967, Suppl 224: 449-451.
Coelho DH, Roland JT, Rush SA, Narayana A, St Clair E, Chung W, Golfinos JG: Small vestibular schwannomas with no hearing: comparison of functional outcomes in stereotactic radiosurgery and microsurgery. Laryngoscope. 2008, 118 (11): 1909-1916. 10.1097/MLG.0b013e31818226cb.
Pierce NE, Antonelli PJ: Endolymphatic hydrops perspectives 2012. Curr Opin Otolaryngol Head Neck Surg. 2012, 20 (5): 416-419. 10.1097/MOO.0b013e328357a6c8.
Strupp M, Brandt T: Peripheral vestibular disorders. Curr Opin Neurol. 2013, 26 (1): 81-89. 10.1097/WCO.0b013e32835c5fd4.
Gibson WPR, Moffat DA, Ramsden RT: Clinical electrocochleography in the diagnosis and management of Menière’s disorders. Int J Audiol. 1977, 16 (5): 389-401. 10.3109/00206097709071852.
Nguyen LT, Harris JP, Nguyen QT: Clinical utility of electrocochleography in the diagnosis and management of Ménière’s disease: AOS and ANS membership survey data. Otol Neurotol. 2010, 31 (3): 455-459. 10.1097/MAO.0b013e3181d2779c.
Sugasawa K, Iwasaki S, Fujimoto C, Kinoshita M, Inoue A, Egami N, Ushio M, Chihara Y, Yamasoba T: Diagnostic usefulness of multifrequency tympanometry for Ménière’s disease. Audiol Neurootol. 2013, 18 (3): 152-160. 10.1159/000346343.
Avan P, Giraudet F, Chauveau B, Gilain L, Mom T: Unstable distortion-product otoacoustic emission phase in Menière’s disease. Hear Res. 2011, 277 (1–2): 88-95.
Don M, Kwong B, Tanaka T: A diagnostic test for Ménière’s disease and cochlear hydrops: Impaired high-pass noise masking of auditory brainstem responses. Otol Neurotol. 2005, 26 (4): 711-722. 10.1097/01.mao.0000169042.25734.97.
Kingma CM, Wit HP: Cochlear Hydrops Analysis Masking Procedure results in patients with unilateral Ménière’s Disease. Otol Neurotol. 2010, 31 (6): 1004-1008. 10.1097/MAO.0b013e3181e8cc49.
Claes GM, Wyndaele M, De Valck CF, Claes J, Govaerts P, Wuyts FL, Van de Heyning PH: Travelling wave velocity test and Ménière’s disease revisited. Eur Arch Otorhinolaryngol. 2008, 265 (5): 517-523. 10.1007/s00405-007-0486-7.
Kingma CM, Wit HP: Asymmetric vestibular evoked myogenic potentials in unilateral Menière patients. Eur Arch Otorhinolaryngol. 2011, 268 (1): 57-61. 10.1007/s00405-010-1345-5.
Taylor RL, Wijewardene AA, Gibson WP, Black DA, Halmagyi GM, Welgampola MS: The vestibular evoked-potential profile of Ménière’s disease. Clin Neurophysiol. 2011, 122 (6): 1256-1263. 10.1016/j.clinph.2010.11.009.
Winters SM, Berg IT, Grolman W, Klis SF: Ocular vestibular evoked myogenic potentials: frequency tuning to air-conducted acoustic stimuli in healthy subjects and Ménière’s disease. Audiol Neurootol. 2012, 17 (1): 12-19. 10.1159/000324858.
Taylor RL, Zagami AS, Gibson WP, Black DA, Watson SR, Halmagyi MG, Welgampola MS: Vestibular evoked myogenic potentials to sound and vibration: characteristics in vestibular migraine that enable separation from Menière’s disease. Cephalalgia. 2012, 32 (3): 213-225. 10.1177/0333102411434166.
Zuniga MG, Janky KL, Schubert MC, Carey JP: Can vestibular-evoked myogenic potentials help differentiate Ménière disease from vestibular migraine?. Otolaryngol Head Neck Surg. 2012, 146 (5): 788-796. 10.1177/0194599811434073.
Fukuoka H, Takumi Y, Tsukada K, Miyagawa M, Oguchi T, Ueda H, Kadoya M, Usami S: Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Meniere’s disease. Acta Otolaryngol. 2012, 132 (2): 141-145. 10.3109/00016489.2011.635383.
Kimura H, Aso S, Watanabe Y: Prediction of progression from atypical to definite Ménière’s disease using electrocochleography and glycerol and furosemide tests. Acta Otolaryngol. 2003, 123 (3): 388-395. 10.1080/0036554021000028079.
Taguchi D, Kakigi A, Takeda T, Sawada S, Nakatani H: Diagnostic value of plasma antidiuretic hormone, electrocochleography, and glycerol test in patients with endolymphatic hydrops. ORL. 2009, 71 (suppl 1): 26-29.
Fletcher RH, Fletcher SW: Clinical epidemiology: the essentials. 2005, Philadelphia: Lippincott Williams & Wilkins, 4
Claes G, Van den Hauwe L, Wuyts F, Van de Heyning P: Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthectomy in Menière’s disease patients?. Eur Arch Otorhinolaryngol. 2012, 269 (2): 413-418. 10.1007/s00405-011-1644-5.
Fiorino F, Pizzini FB, Barbieri F, Beltramello A: Variability in the perilymphatic diffusion of gadolinium does not predict the outcome of intratympanic gentamicin in patients with Ménière’s disease. Laryngoscope. 2012, 122 (4): 907-911. 10.1002/lary.23211.
Gürkov R, Flatz W, Keeser D, Strupp M, Ertl-Wagner B, Krause E: Effect of standard-dose betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol. 2013, 270 (4): 1231-1235. 10.1007/s00405-012-2087-3.
Mom T, Gilain L, Avan P: Effects of glycerol intake and body tilt on otoacoustic emissions reflect labyrinthine pressure changes in Menière’s disease. Hear Res. 2009, 250 (1–2): 38-45.
Gibbin KP, Mason SM, Singh CB: Glycerol dehydration tests in Ménière’s disorder using extratympanic electrocochleography. Clin Otolaryngol Allied Sci. 1981, 6 (6): 395-400. 10.1111/j.1365-2273.1981.tb01818.x.
Magliulo G, Cuiuli G, Gagliardi M, Ciniglio-Appiani G, D’Amico R: Vestibular evoked myogenic potentials and glycerol testing. Laryngoscope. 2004, 114 (2): 338-343. 10.1097/00005537-200402000-00030.
Moon IJ, Park GY, Choi J, Cho YS, Hong SH, Chung WH: Predictive value of electrocochleography for determining hearing outcomes in Ménière’s disease. Otol Neurotol. 2012, 33 (2): 204-210. 10.1097/MAO.0b013e318241b88c.
Futaki T, Kitahara M, Morimoto M: A comparison of the furosemide and glycerol tests for Meniere’s disease. With special reference to the bilateral lesion. Acta Otolaryngol. 1977, 83 (3–4): 272-278.
Angelborg C, Klockhoff I, Stahle J: Urea and hearing in patients with Meniere’s disease. Scand Audiol. 1977, 6 (3): 143-146. 10.3109/01050397709043115.
Van de Water SM, Arenberg IK, Balkany TJ: Auditory dehydration testing: glycerol versus urea. Am J Otol. 1986, 7 (3): 200-203. 10.1016/S0196-0709(86)80007-2.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6815/14/12/prepub